-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Core Laboratories Inc. /DE/ quarterly/annual Income Tax Expense (Benefit) history and change rate from 2021 to Q3 2025.
- Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $3.75M, a 20% decline year-over-year.
- Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $11.5M, a 37.9% decline year-over-year.
- Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2024 was $14M, a 235% increase from 2023.
- Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2023 was $4.19M, a 59.4% decline from 2022.
- Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2022 was $10.3M, a 35.2% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)